| Net Cash Provided by (Used in) Operating Activities |
10.9M |
USD |
-89.5% |
Q1 2025 |
|
| Net Cash Provided by (Used in) Financing Activities |
30.3M |
USD |
|
Q1 2025 |
|
| Net Cash Provided by (Used in) Investing Activities |
-77.8M |
USD |
+23.5% |
Q1 2025 |
|
| Common Stock, Shares Authorized |
140M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
54.8M |
shares |
+0.47% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-36.5M |
USD |
+17.6% |
Q1 2025 |
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
344M |
USD |
-41.7% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
44.7M |
USD |
+8.92% |
Q4 2024 |
|
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.13 |
pure |
|
Q1 2025 |
|
| Deferred Tax Assets, Gross |
94.1M |
USD |
+15.1% |
Q4 2024 |
|
| Payments to Acquire Property, Plant, and Equipment |
396M |
USD |
+175% |
Q3 2023 |
Q3 2023 |
| Deferred Income Tax Expense (Benefit) |
-6.54M |
USD |
-325% |
Q1 2025 |
|
| Deferred Tax Assets, Operating Loss Carryforwards |
48.8M |
USD |
+1.8% |
Q4 2024 |
|
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2024 |
|
| Additional Paid in Capital |
296M |
USD |
+4.7% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Depreciation, Depletion and Amortization |
171M |
USD |
+22% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
49.4M |
USD |
+21.4% |
Q4 2024 |
|
| Interest Expense |
1.12M |
USD |
-84.9% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |